• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012 Product Image

Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

  • Published: December 2008
  • Region: Egypt
  • 111 pages
  • Global Markets Direct

FEATURED COMPANIES

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • bioMerieux S.A.
  • F. Hoffmann-La Roche Ltd.
  • MORE

Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2012

Summary

This report is an essential source for in-depth information and data relating to the Egypt In vitro diagnostic dvices market. It also offers detailed and comprehensive coverage of market revenue, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the in vitro diagnostics market in Egypt

Scope

- The report provides in vitro diagnostics information broken down into detailed categories and segments in Egypt.
- Total revenues, end users
- Market shares of all the key competitors.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, READ MORE >

1 2
1.1 List of Tables 8
1.2 List of Figures 10
2 Introduction 12
2.1 What Is This Report About? 12
3 Definitions of Markets Covered in the Report 13
3.1 In Vitro Diagnostics Devices 13
3.2 Clinical Chemistry Test Reagents 13
3.2.1 Laboratory Reagents 13
3.2.2 Clinical Chemistry Calibrators and Controls 13
3.2.3 Clinical Chemistry Rapid Tests 13
3.3 Immunochemistry Test Reagents 13
3.3.1 Disease Specific Markers 13
3.3.2 Disease Specific Test Reagents 14
3.3.3 Drug Related Testing Reagents 14
3.3.4 Hormone Related Testing Reagents 15
3.3.5 Immunochemistry Calibrators and Controls 15
3.3.6 Immunochemistry Rapid Tests 15
3.4 Blood Test Reagents 16
3.4.1 Hematology Test Reagents 16
3.4.2 Hemostasis Test Reagents 16
3.4.3 Tissue Typing Reagents 17
3.4.4 Monoclonal Antibodies 17
3.4.5 Cytokines and Immunomodulators 17
3.4.6 Histology and Cytology Reagents 17
3.5 Microbiology Test Reagents 17
3.5.1 Bacteriology Test Reagents 17
3.5.2 Microbiology Calibrators and Controls 18
3.5.3 Microbiology Rapid Tests 18
3.6 Infectious Immunology Test Reagents 18
3.6.1 Bacteriology 18
3.6.2 Virology 18
3.6.3 Parasitology 19
3.6.4 Infectious Immunology Calibrators and Controls 19
3.6.5 Infectious Immunology Rapid Tests 19
3.7 Genetic Test Reagents 19
3.8 Self Testing 19
3.9 Instruments 19
4 Healthcare Sector Review 20
5 Regulation System 21
5.1 Approval Process 21
5.2 Registration Procedures 22
5.3 Registration of Class I, Class IIa and Class IIb devices at DPPC 22
5.4 Declaration of Conformity (Self certification) 23
5.5 Free Sale Certificate 23
5.6 CE Certificate 24
6 Pricing and Reimbursement 25
7 Distribution Structure 26
8 In Vitro Diagnostics In Egypt 27
8.1 In Vitro Diagnostics Cross Country Comparison (2000-2012) 27
8.2 In Vitro Diagnostics, Egypt, Overall Revenues ($ mn), 2000-2012 28
8.3 In Vitro Diagnostics, Egypt Company share (2006-2007) 34
9 Blood Test Reagents In Egypt 35
9.1 Blood Test Reagents Overall Revenue (2000-2012) 35
9.1.1 Haematology Test Reagents Overall Revenues (2000-2012) 39
9.1.2 Hemostasis Test Reagents Overall Revenues (2000-2012) 41
9.2 Blood Test Reagents Distribution Share (2006-2007) 43
9.3 Blood Test Reagents, Egypt, Company Share (2006-2007) 44
10 Clinical Chemistry Test Reagents In Egypt 45
10.1 Clinical Chemistry Test Reagents Overall Revenue (2000-2012) 45
10.2 Clinical Chemistry Test Reagents Distribution Share (2006-2007) 48
10.3 Clinical Chemistry Test Reagents, Egypt, Company Share (2006-2007) 49
11 Genetic Test Reagents In Egypt 50
11.1 Genetic Test Reagents Overall Revenue (2000-2012) 50
11.2 Genetic Test Reagents Distribution Share (2006-2007) 52
11.3 Genetic Test Reagents, Egypt, Company Share (2006-2007) 53
12 Immunochemistry Test Reagents In Egypt 54
12.1 Immunochemistry Test Reagents Overall Revenue (2000-2012) 54
12.1.1 Disease Specific Markers Overall Revenues (2000-2012) 58
12.1.2 Disease Specific Test Reagents Overall Revenues (2000-2012) 59
12.1.3 Drug Related Testing Reagents Overall Revenues (2000-2012) 62
12.1.4 Hormone Related Testing Reagents Overall Revenues (2000-2012) 64
12.2 Immunochemistry Test Reagents Distribution Share (2006-2007) 65
12.3 Immunochemistry Test Reagents, Egypt, Company Share (2006-2007) 66
13 Infectious Immunology Test Reagents In Egypt 67
13.1 Infectious Immunology Test Reagents Overall Revenue (2000-2012) 67
13.1.1 Virology Overall Revenues (2000-2012) 71
13.2 Infectious Immunology Test Reagents Distribution Share (2006-2007) 73
13.3 Infectious Immunology Test Reagents, Egypt, Company Share (2006-2007) 74
14 Instruments In Egypt 75
14.1 Instruments Overall Revenue (2000-2012) 75
14.2 Instruments Distribution Share (2006-2007) 77
15 Microbiology Test Reagents In Egypt 78
15.1 Microbiology Test Reagents Overall Revenue (2000-2012) 78
15.1.1 Bacteriology Test Reagents Overall Revenues (2000-2012) 79
15.2 Microbiology Test Reagents Distribution Share (2006-2007) 81
15.3 Microbiology Test Reagents, Egypt, Company Share (2006-2007) 82
16 Self Testing In Egypt 83
16.1 Self Testing Overall Revenue (2000-2012) 83
16.2 Self Testing Distribution Share (2006-2007) 85
16.3 Self Testing, Egypt, Company Share (2006-2007) 86
17 F. Hoffmann-La Roche Ltd. Company Profile 87
17.1 Company Overview 87
17.2 Value Chain Analysis 87
17.2.1 Manufacturing 88
17.2.2 Product Development 88
17.2.3 Sales and Marketing 89
18 Abbott Laboratories Company Profile 91
18.1 Company Overview 91
18.2 Value Chain Analysis 91
18.2.1 Manufacturing 92
18.2.2 Product Development 92
18.2.3 Sales and Marketing 93
18.2.4 Abbott Laboratories Pipeline Products by Equipment Type 93
18.2.5 Abbott Laboratories Pipeline Products by Development Stage 94
18.2.6 Abbott Laboratories Pipeline Products by Therapy Area 94
18.2.7 Abbott Laboratories Pipeline Products by Clinical Trials 94
18.2.8 Abbott Laboratories Pipeline Products by News Summary 94
19 Beckman Coulter, Inc. Company Profile 95
19.1 Company Overview 95
19.2 Value Chain Analysis 95
19.2.1 Manufacturing 96
19.2.2 Product Development 96
19.2.3 Sales and Marketing 96
19.3 Beckman Coulter, Inc. Pipeline Products 97
19.3.1 Beckman Coulter, Inc. Pipeline Products By Equipment Type 97
19.3.2 Beckman Coulter, Inc. Pipeline Products by Development Stage 98
19.3.3 Beckman Coulter, Inc. Pipeline Products by Therapy Area 99
19.3.4 Beckman Coulter, Inc. Pipeline Products by News Summary 99
20 Dade Behring Holdings, Inc. Company Profile 100
20.1 Company Overview 100
20.1.1 Dade Behring Holdings, Inc. Pipeline Products by Equipment Type 101
20.1.2 Dade Behring Holdings, Inc. Pipeline Products by Development Stage 101
20.1.3 Dade Behring Holdings, Inc. Pipeline Products by Therapy Area 101
20.1.4 Dade Behring Holdings, Inc. Pipeline Products by News Summary 101
21 bioMerieux S.A. Company Profile 102
21.1 Company Overview 102
21.2 Value Chain Analysis 102
21.2.1 Manufacturing 103
21.2.2 Product Development 103
21.2.3 Sales and Marketing 104
22 Ortho-Clinical Diagnostics Inc. Company Profile 105
22.1 Company Overview 105
23 Appendix 106
23.1 Global Markets Direct Research Methodology 106
23.2 Coverage 107
23.3 Secondary Research 107
23.4 Primary Research 108
23.5 Models 108
23.6 Forecasts 109
23.7 Expert Panels 109
23.8 Currency Conversion 110
23.9 Contact Us 111
23.10 Disclaimer 111

Executive Summary

1.2 List of Figures
Figure 1: In Vitro Diagnostics Cross Country Comparison (2000-2012) 27
Figure 2: In Vitro Diagnostics, Egypt, Overall Revenues ($ mn), 2000-2012 28
Figure 3: In Vitro Diagnostics, Egypt, Portfolio Analysis, 2000-2012 29
Figure 4: In Vitro Diagnostics, Egypt, Overall Revenues ($ mn), Historic, 2000-2007 30
Figure 5: In Vitro Diagnostics, Egypt, Overall Revenues ($ mn), Forecast, 2007-2012 32
Figure 6: In Vitro Diagnostics, Egypt Company share (%), 2007 34
Figure 7: Blood Test Reagents, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 35
Figure 8: Blood Test Reagents, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 37
Figure 9: Haematology Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 39
Figure 10: Haematology Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 40
Figure 11: Hemostasis Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 41
Figure 12: Hemostasis Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 42
Figure 13: Blood Test Reagents, Egypt, Company Share (%), 2007 44
Figure 14: Clinical Chemistry Test Reagents, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 45
Figure 15: Clinical Chemistry Test Reagents, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 46
Figure 16: Clinical Chemistry Test Reagents, Egypt, Company Share (%), 2007 49
Figure 17: Genetic Test Reagents, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 50
Figure 18: Genetic Test Reagents, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 51
Figure 19: Genetic Test Reagents, Egypt, Company Share (%), 2007 53
Figure 20: Immunochemistry Test Reagents, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 54
Figure 21: Immunochemistry Test Reagents, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 56
Figure 22: Disease Specific Markers, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 58
Figure 23: Disease Specific Markers, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 59
Figure 24: Disease Specific Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 60
Figure 25: Disease Specific Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 61
Figure 26: Drug Related Testing Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 62
Figure 27: Drug Related Testing Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 63
Figure 28: Immunochemistry Test Reagents, Egypt, Company Share (%), 2007 66
Figure 29: Infectious Immunology Test Reagents, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 67
Figure 30: Infectious Immunology Test Reagents, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 69
Figure 31: Virology, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 71
Figure 32: Virology, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 72
Figure 33: Infectious Immunology Test Reagents, Egypt, Company Share (%), 2007 74
Figure 34: Instruments, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 75
Figure 35: Instruments, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 76
Figure 36: Bacteriology Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Historic, 2000-2007 79
Figure 37: Bacteriology Test Reagents, Egypt, Revenues ($ mn) by Sub-Segment, Forecast, 2007-2012 80
Figure 38: Microbiology Test Reagents, Egypt, Company Share (%), 2007 82
Figure 39: Self Testing, Egypt, Revenue ($ mn) by Segment, Historic, 2000-2007 83
Figure 40: Self Testing, Egypt, Revenue ($ mn) by Segment, Forecast, 2007-2012 84
Figure 41: Self Testing, Egypt, Company Share (%), 2007 86
Figure 42: F. Hoffmann-La Roche Ltd Value Chain Analysis 87
Figure 43: Abbott Laboratories Value Chain Analysis 91
Figure 44: Beckman Coulter, Inc. Value Chain Analysis 95
Figure 45: Biomerieux Sa Value Chain Analysis 102
Figure 46: Global Markets Direct Methodology 106

F. Hoffmann-La Roche Ltd.
Abbott Laboratories
Beckman Coulter, Inc.
Dade Behring Holdings, Inc.
bioMerieux S.A.
Ortho-Clinical Diagnostics Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos